Stockscreener 앱 받기
87.60
1.73%
1.38
Bright Minds Biosciences Inc 주식(DRUG)의 최신 뉴스
This Insider Has Just Sold Shares In Bright Minds Biosciences - simplywall.st
DRUG SEC FilingsBright Minds Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Cormorant sells $9.78m in Bright Minds Biosciences stock - Investing.com UK
[SCHEDULE 13G/A] BRIGHT MINDS BIOSCIENCES INC. Amended Passive Investment Disclosure - Stock Titan
Insider Selling: Bright Minds Biosciences (NASDAQ:DRUG) Major Shareholder Sells 109,331 Shares of Stock - MarketBeat
Bright Minds Biosciences (DRUG) holder sells 109,331 shares in open market - Stock Titan
Bright Minds announces ATM offering up to $100 million - MSN
How Bright Minds Biosciences Inc. (DRUG) Affects Rotational Strategy Timing - Stock Traders Daily
Bright Minds (DRUG) Year-Ahead Outlook | Q4 2025: Earnings ReportSurprise Score - Cổng thông tin điện tử tỉnh Tây Ninh
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Top 3 Canadian Biotech Stocks in 2026 - Investing News Network
Bright Minds Biosciences (NASDAQ:DRUG) Downgraded to Sell Rating by Wall Street Zen - MarketBeat
Shroom stocks rise as Trump is said to sign executive order on psychedelic drug - Seeking Alpha
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Sees Significant Growth in Short Interest - MarketBeat
(DRUG) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Bright Minds Biosciences (NASDAQ:DRUG) Earns Buy Rating from Analysts at Jefferies Financial Group - MarketBeat
Jefferies initiates Bright Minds stock with buy on epilepsy drug By Investing.com - Investing.com South Africa
Jefferies initiates Bright Minds stock with buy on epilepsy drug - Investing.com
Total debt per share of Bright Minds Biosciences Inc. – NEO:DRUG - TradingView
Certain RSUs of Bright Minds Biosciences Inc. are subject to a Lock-Up Agreement Ending on 8-APR-2026. - marketscreener.com
Certain Options of Bright Minds Biosciences Inc. are subject to a Lock-Up Agreement Ending on 8-APR-2026. - marketscreener.com
7,787,161 Common Shares of Bright Minds Biosciences Inc. are subject to a Lock-Up Agreement Ending on 8-APR-2026. - marketscreener.com
Bright Minds Biosciences (NASDAQ:DRUG) Shares Gap UpHere's Why - MarketBeat
Pullback Watch: Is Bright Minds Biosciences Inc a cyclical or defensive stockRecession Risk & Target Return Focused Stock Picks - baoquankhu1.vn
Bright Minds Biosciences (NASDAQ:DRUG) Trading 7.4% HigherWhat's Next? - MarketBeat
Sentiment Watch: What is PROVs 5 year growth outlookWeekly Profit Recap & Proven Capital Preservation Methods - baoquankhu1.vn
Responsive Playbooks and the DRUG Inflection - Stock Traders Daily
Bright Minds Biosciences Inc. (DRUG.NE) interactive stock chart - Yahoo Finance UK
Bright Minds Biosciences Inc. (DRUG.NE) Stock Forum & Discussion - Yahoo! Finance Canada
Bright Minds Biosciences Inc Live Share Prices and Trades. DRUG.US Live Streaming Share Prices. - London South East
Swing Trade: Whats the profit margin of WB PRCCLTrade Exit Report & Community Verified Watchlist Alerts - baoquankhu1.vn
Bright Minds Biosciences (NASDAQ:DRUG) Given Buy Rating at BTIG Research - Defense World
Bright Minds Biosciences (NASDAQ:DRUG) Earns Buy Rating from BTIG Research - MarketBeat
BTIG reiterates Bright Minds Biosciences stock rating on seizure treatment potential - Investing.com India
What is the probability of success for Bright Minds Biosciences Inc (DRUG)’s lead drug candidate? - msn.com
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Average Recommendation of “Moderate Buy” from Brokerages - defenseworld.net
Hedge Fund Bets: How much upside does Bright Minds Biosciences Inc have2026 Macro Moves & Weekly Top Stock Performers List - baoquankhu1.vn
What Is the Probability of Success for Bright Minds Biosciences Inc (DRUG)’s Lead Drug Candidate? - Yahoo Finance
Understanding the Setup: (DRUG) and Scalable Risk - Stock Traders Daily
Bright Minds Biosciences (NASDAQ:DRUG) Raised to "Hold" at Wall Street Zen - MarketBeat
Risk Off: Is PMTPRC showing insider buying2026 Decliners & Trade Opportunity Analysis Reports - baoquankhu1.vn
Pullback Watch: Is Bright Minds Biosciences Inc undervalued by DCF analysis2026 Price Momentum & Expert Approved Momentum Ideas - baoquankhu1.vn
303,685 Shares in Bright Minds Biosciences Inc. $DRUG Acquired by Braidwell LP - MarketBeat
0.78%
3.99%
자본화:
|
볼륨(24시간):